TEST-EGFR-PLASMA
TEST-EGFR-PLASMA
The reagent kit is used in the examination of patients diagnosed with non-small cell lung cancer (NSCLC) to determine indications for targeted therapy with EGFR tyrosine kinase inhibitors and monitor response to them.
Advantages
- Detects 29 mutations of the EGFR gene
- The liquid biopsy method allows for continuous monitoring of the patient's condition and making prompt changes to the treatment program.
- Can be used when adequate tumor sample is not available.
Reagent kits cannot be used to diagnose any pathology and are intended only for qualitative determination of the EGFR gene mutation status to determine indications for targeted therapy.
Detection method
Real-time PCR
Analysis type
Qualitative
Samples
Blood plasma
Analytical sensitivity
1 copy of the EGFR gene per 1 µl of the DNA solution
Sensirtivity
88,1 %
Specificity
96 %
Time per 1 analysis
120 minutes
Equipment
CFX96, DTPrime, Rotor-Gene Q, QuantStudio 5
Number of isolations
12 / 24
Transportation and
Storage conditions
Storage conditions
-18 …-25 °C 12 months
+2 …+8 °C Up tp 3 days
до +25 °C Up tp 3 days
+2 …+8 °C Up tp 3 days
до +25 °C Up tp 3 days
Designed by